• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR Back to Search Results
Model Number G150
Device Problems Failure to Capture (1081); Pacing Problem (1439); Capturing Problem (2891)
Patient Problems Congestive Heart Failure (1783); Fatigue (1849)
Event Date 11/10/2016
Event Type  Injury  
Manufacturer Narrative
The local area sales representative was contacted for additional information.At this time, no further information is available.Should additional information become available this report will be updated.
 
Event Description
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) and right ventricular (rv) lead exhibited high threshold measurements four months post implant.X-rays and fluoroscopic imaging were reviewed and noted no lead dislodgement.A revision procedure was performed and the lead was successfully repositioned and satisfactory threshold measurements were obtained.The root cause was unable to be determined.Subsequently, high thresholds and loss of capture (loc) were later observed.The root cause was still unable to be determined.The patient experienced worsening heart failure symptoms of shortness of breath (sob) and fatigue due to the lack of biventricular pacing.An additional procedure was attempted to explant the lead, however, access was unable to be gained due to scar tissue, so the procedure was abandoned.The patient will be referred for lead explant on an unknown date in the future.No additional adverse patient effects were reported.This product remains implanted and in service.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information was received that the rv lead was observed to have dislodged.An invasive procedure was performed.The lead was explanted and replaced.This crt-d remains implanted and in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN
Type of Device
IMPLANTABLE CHF GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key6677768
MDR Text Key78717457
Report Number2124215-2017-11343
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534614
UDI-Public(01)00802526534614(17)20180331
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/31/2018
Device Model NumberG150
Other Device ID NumberDYNAGEN CRT-D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received06/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/31/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0293; 4076; 4194; 6931; G150; MISMATCH
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age80 YR
-
-